SCHEMBL7903182

SCHEMBL7903182

Cc1ccc2c(c1)NC(c1cccnc1)C2

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 7/20 0.45
CHRNA4 P43681 7/20 0.45
MAPT P10636 4/20 0.44
NPSR1 Q6W5P4 2/20 0.44
TSHR P16473 1/20 0.44
TDP1 Q9NUW8 2/20 0.43
HTT P42858 1/20 0.43
CHRNA7 P36544 6/20 0.42
CYP2A6 P11509 3/20 0.41
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
CYP2D6 P10635 2/20 0.41
CYP2C19 P33261 2/20 0.41
POLB P06746 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP19A1 P11511 2/20 0.40
ALDH1A1 P00352 2/20 0.39
CHRNB4 P30926 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14522626 0.83 TRPM5 (0.44) MAPTMEN1KMT2AKDM4ETRPM5
SCHEMBL7901471 0.82 CHRNB2 (0.45) CHRNB2CHRNA4MAPTCHRNA7CYP2A6
SCHEMBL7900671 0.81 CHRNB2 (0.50) CHRNB2CHRNA4MAPTCHRNA7CYP2A6
SCHEMBL16589775 0.79 ESR1 (0.46) CHRNB2CHRNA4MAPTNPSR1TSHR
SCHEMBL7901769 0.73 MEN1 (0.46) CHRNB2CHRNA4MAPTTSHRTDP1
SCHEMBL2349856 0.72 TRPM5 (0.43) MAPTMEN1KMT2AKDM4ETRPM5
SCHEMBL156842 0.71 CHRNB2 (0.56) CHRNB2CHRNA4MAPTNPSR1TSHR
SCHEMBL26703813 0.69 MEN1 (0.44) CHRNB2CHRNA4MAPTTDP1CHRNA7
SCHEMBL6986386 0.69 CHRNB2 (0.46) CHRNB2CHRNA4MAPTNPSR1TSHR
SCHEMBL13964615 0.68 AR (0.46) MAPTTDP1MEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010111634-A2 RENIN INHIBITORS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-09-30 WO disclosed